The European Commission Horizon 2020 Program Backs Filterlex’s Embolic Protection Device – CAPTIS

€2.1M Grant to support Filterlex’s CAPTIS clinical trials Yokneam, Israel (September 16, 2019) – Filterlex Medical, an innovative medical device startup in the cardiovascular field,  today announced that the company has been selected for the Phase 2 Horizon 2020 SME Instrument program. The SME Instrument program awards financial support to companies that demonstrate world class …

The European Commission Horizon 2020 Program Backs Filterlex’s Embolic Protection Device – CAPTIS Read More »